Copertina

Puerarin Decreases the Expression of FUS‐Dependent MAPK4 to Inhibit the Development of Triple‐Negative Breast Cancer

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Jian Guo, Huiheng Qu, Zhigang Huang, Yu Xue
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Chemical Biology & Drug Design
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Discovery of New 4‐Aminoquinoline–Thiazolidinone Hybrid Analogs as Antiproliferative Agents Inhibiting TLR4–LPS‐Mediated Migration in Triple‐Negative Breast Cancer Cells
di: S. K. Batin Rahaman, et al.
Pubblicazione: (2025)

Bruceine A Suppresses Triple‐Negative Breast Cancer Growth and Metastasis by Inducing GPX4 ‐Dependent Ferroptosis via Ubiquitin–Proteasome‐Mediated Degradation
di: Hengguan Cui, et al.
Pubblicazione: (2026)

Selective Antiproliferative and Apoptotic Effects of 2,6‐Diketopiperazines on MDA‐MB‐231 Triple‐Negative Breast Cancer
di: Flor Paulina Garrido González, et al.
Pubblicazione: (2025)

Oridonin Alleviates Doxorubicin‐Induced Cardiotoxicity by Inhibiting p38 MAPK/MMP3 Signaling Pathway
di: Xingyuan Hou, et al.
Pubblicazione: (2025)

Dehydroepiandrosterone‐α‐2‐Deoxyglucoside Exhibits Enhanced Anticancer Effects in MCF‐7 Breast Cancer Cells and Inhibits Glucose‐6‐Phosphate Dehydrogenase Activity
di: Hsu‐Feng Liu, et al.
Pubblicazione: (2024)

Exploring the Mechanism of Myrrh in the Treatment of Breast Cancer Based on Network Pharmacology and Cell Experiments
di: Wu Tao, et al.
Pubblicazione: (2024)

99mTc‐HYNIC PEGylated Peptide Probe Targeting HER2‐Expression in Breast Cancer
di: Sushree Arpitabala Yadav, et al.
Pubblicazione: (2025)

Multifaceted In Silico Screening Strategies Identifies Potent Inhibitors Facilitating Inhibition of ZNF726 Activity in Breast Cancer
di: Shreetama Bandyopadhayaya, et al.
Pubblicazione: (2025)

Madecassoside Induces Apoptosis and Inhibits Migration by Regulating ROS ‐Mediated Signaling Pathways in MDA ‐ MB ‐231 Breast Cancer Cells
di: Wen‐Shuang Hou, et al.
Pubblicazione: (2025)

Ailanthone Restrains Osteosarcoma Growth and Metastasis by Decreasing the Expression of Regulator of G Protein Signaling 4 and Twist Family BHLH Transcription Factor 1
di: Qiang Tan, et al.
Pubblicazione: (2025)

Procyanidin Alleviates Diabetic Retinopathy by Activating the Expression of Activating Transcription Factor 1 Expression to Upregulate Synoviolin 1 and Inhibit the High Mobility Group Box 1/Toll‐Like Receptor 4 Pathway
di: Limin Zheng, et al.
Pubblicazione: (2025)

From Virtual Screening to Cell Phenotype: 4‐Thiazolidone Scaffolds Targeting LOXL2 in Breast Cancer
di: Sandra Ferreira, et al.
Pubblicazione: (2026)

Baicalein Targets MAPK9 to Induce Apoptosis of Hepatocellular Carcinoma Cells
di: Weili Wang, et al.
Pubblicazione: (2024)

Network Pharmacology and Transcriptomic Analysis Reveal the Mechanism by Which Ginsenoside CK Remodels the Tumor Immune Microenvironment to Inhibit Liver Cancer Progression
di: Fangzhi Ye, et al.
Pubblicazione: (2025)

Novel 10‐Alkoxy 1,4‐Dien‐3‐One Estranes as Multitarget Anticancer Agents Against Estrogen‐Positive Breast Cancer
di: Ivana Kuzminac, et al.
Pubblicazione: (2026)

Pyrrole‐Tethered Bisbenzoxazole Derivatives: Apoptosis‐Inducing Agents Targeting Breast Cancer Cells
di: Burak Kuzu, et al.
Pubblicazione: (2025)

Kaempferol attenuates inflammation in lipopolysaccharide‐induced gallbladder epithelial cells by inhibiting the MAPK/NF‐κB signaling pathway
di: Hai‐tao Wu, et al.
Pubblicazione: (2024)

Icaritin Inhibits Malignant Progression and Enhances Ferroptosis and Bortezomib Sensitivity by Suppressing HSP90AA1 Expression in Multiple Myeloma
di: Lin Shi, et al.
Pubblicazione: (2026)

Skullcapflavone II Suppresses Colorectal Cancer by Inhibiting the HIF ‐1α‐Glycolysis Pathway
di: Shiwei Yang, et al.
Pubblicazione: (2025)

Pyrazoline–Imidazopyridine Hybrids as Beclin‐1 Mimetics Driving Dual Apoptotic and Autophagy in Breast Cancer
di: Rashmi Shivakumar, et al.
Pubblicazione: (2026)

δ‐Tocotrienol Potentiates Breast and Prostate Cancer Cells to Paclitaxel via Suppressing PD‐L1‐Mediated Cancer‐Promoting Signaling
di: Zhenou Sun, et al.
Pubblicazione: (2025)

Prediction of Breast Cancer Lymph Node Metastasis by a Nomogram Model Integrating Pathomics, Radiomics, and Immunoscore
di: Tian Xu, et al.
Pubblicazione: (2026)

Mollugin Derivatives as Anti‐Inflammatory Agents: Design, Synthesis, and NF‐κB Inhibition
di: Yuan‐Liang Gao, et al.
Pubblicazione: (2024)

Investigating the Role of Quercetin, an Active Ingredient in Bazhen Decoction, in Targeting CXCL8 to Inhibit Macrophage M2 Polarization and Reshape the Immunological Microenvironment of Colorectal Cancer
di: Wenwu Wang, et al.
Pubblicazione: (2025)

Anti‐metastatic Effects of Bee Venom and Melittin in Breast Cancer Cells by Upregulation of BRMS1 and DRG1 Genes
di: Nur Sena Sivri, et al.
Pubblicazione: (2024)

Plumbagin's Antiproliferative Mechanism in Human Cancer Cells: A Copper‐Dependent Cytotoxic Approach
di: Mohamed El Oirdi
Pubblicazione: (2024)

Anti‐Proliferative and Apoptotic Evaluation of a Novel Synthesized Acridine Hybrid With Anticipated Synergistic Effect to Paclitaxel on Breast Cancer Cells
di: Esraa A. Aidy, et al.
Pubblicazione: (2026)

Correction to Plumbagin's Antiproliferative Mechanism in Human Cancer Cells: A Copper‐Dependent Cytotoxic Approach
Pubblicazione: (2024)

The Potent Antioxidant 3,5‐Dihydroxy‐4‐Methoxybenzyl Alcohol Reveals Anticancer Activity by Targeting Several Signaling Pathways in Bone Metastatic Human Breast Cancer MDA‐MB‐231 Cells
di: Masayoshi Yamaguchi, et al.
Pubblicazione: (2025)

Stigmasterol Inhibits Glioma Metastasis and Angiogenesis by Regulating Macrophage Polarization
di: Xiangying Li, et al.
Pubblicazione: (2026)

Design and Development of Novel Hybrids Based on Pyrrolo[2,1‐f][1,2,4]Triazine and 1‐(Methylpiperidin‐4‐yl) Aniline–Based Analogs: Exploring the Utility as Anticancer Agents via MERTK Inhibition
di: Balaji Dashrath Sathe, et al.
Pubblicazione: (2024)

Pachymic Acid Suppresses Endometrial Cancer Cell Migration by Inhibiting the NR3C1 / TGF ‐β/Smad Signaling Pathway
di: Yaqiong Wang, et al.
Pubblicazione: (2025)

Tyramine Derivatives as Versatile Pharmacophores With Potent Biological Properties: Sex Hormone–Binding Globulin Inhibition, Colon Cancer Antimigration, and Antimicrobial Activity
di: Jovana S. Marjanović, et al.
Pubblicazione: (2024)

Polyphyllin VII Enhances the Sensitivity of Prostate Cancer Cells to Docetaxel by Promoting Mitochondrial Dysfunction and Inducing Ferroptosis
di: Yun‐Yi Chen, et al.
Pubblicazione: (2025)

Dl‐3‐n‐Butylphthalide Inhibits Autophagy to Alleviate the Neuronal Apoptosis After Spinal Cord Injury by Elevating YAP via Inactivating the Hippo Signaling Pathway
di: Shengsen Yang, et al.
Pubblicazione: (2025)

Relaxin‐2 Alleviates Hyperoxia‐Induced Acute Lung Injury in Neonatal Rats by Inhibiting TLR4/NF‐κB
di: Mei Yang, et al.
Pubblicazione: (2025)

Spalt‐Like Transcription Factor 4 Mediates Fatty Acid Oxidation to Foster 5‐Fluorouracil Resistance in Gastric Cancer Cells
di: Yong Zhu, et al.
Pubblicazione: (2025)

Attempts to Achieve Targeted Covalent Inhibition of Hsp90 β
di: Terin D'Amico, et al.
Pubblicazione: (2026)

Molecular Mechanisms and Efficacy of Tislelizumab, a PD ‐1 Inhibitor Developed in China, in Non‐Small Cell Lung Cancer
di: Yihao Liu, et al.
Pubblicazione: (2026)

Glycyrrhizic acid inhibits DNA damage repair and enhances cisplatin‐induced apoptosis of melanoma cells
di: Fang Bian, et al.
Pubblicazione: (2024)